መነሻ › ማይሎፋይብሮሲስ › Texas › Houston
በHouston፣ TX ለማይሎፋይብሮሲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለማይሎፋይብሮሲስ የሚደረጉ 19 ጥናቶች በHouston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- MD Anderson Cancer Center, Houston
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- MD Anderson Cancer Center, Houston
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The University of Texas, MD Anderson Cancer Center, Houston
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
ተሳታዮችን በመፈለግ ላይደረጃ 3
- MD Anderson Cancer Center, Houston
- The University of Utah-Huntsman Cancer Institute, Houston
- LUMI Research, Houston
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- MD Anderson, Houston
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- MD Anderson Cancer Center, Houston
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MD Anderson Cancer Center, Houston
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Texas M. D. Anderson Cancer Center, Houston
Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- MD Anderson Cancer Center, Houston
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ተሳታዮችን በመፈለግ ላይደረጃ 1
- MD Anderson Cancer Center, Houston
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- GSK Investigational Site, Houston
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Md Anderson Cancer Center, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MD Anderson, Houston
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
ተሳታዮችን በመፈለግ ላይደረጃ 2
- MD Anderson, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Houston
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
ተሳታዮችን በመፈለግ ላይደረጃ 3
- U.T. MD Anderson Cancer Center, Houston
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The University of Texas MD Anderson Cancer Center, Houston
Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- The University of Texas MD Anderson Cancer Center, Houston
በሌሎች ከተሞች ለማይሎፋይብሮሲስ የሚደረጉ ጥናቶች
- New York City, NY18 ጥናቶች
- Boston, MA12 ጥናቶች
- Durham, NC12 ጥናቶች
- Columbus, OH11 ጥናቶች
- Seattle, WA11 ጥናቶች
- Miami, FL10 ጥናቶች
- Salt Lake City, UT10 ጥናቶች
- Atlanta, GA9 ጥናቶች
- Tampa, FL9 ጥናቶች
- Nashville, TN9 ጥናቶች
- Cleveland, OH9 ጥናቶች
- Baldwin Park, CA9 ጥናቶች
በHouston ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር145 ጥናቶች
- የጡንቻ ካንሰር126 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)121 ጥናቶች
- Metastatic Cancer104 ጥናቶች
- የኮሎሬክታል ካንሰር102 ጥናቶች
- የእንቁላል ካንሰር89 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ85 ጥናቶች
- የሳንባ ካንሰር78 ጥናቶች
- የፕሮስቴት ካንሰር76 ጥናቶች
- የኤንዶሜትሪየም ካንሰር68 ጥናቶች
- የፓንክሪያስ ካንሰር61 ጥናቶች
- ሜላኖማ59 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።